Investor Presentaiton
Disclaimer
This presentation (the "Presentation") has been prepared by PolyPeptide Group AG ("PolyPeptide" and together with its subsidiaries, "we", "us" or the "Group"). The information contained in the Presentation
does not purport to be comprehensive. Please refer to the financial reports available on our website at https://report.polypeptide.com/hyr/21.
PolyPeptide, together with its directors, officers, employees and advisors, make no representation or warranty, express or implied, as to, and accordingly no reliance should be placed on, the fairness,
reasonableness, accuracy, or completeness or correctness of the information contained in the Presentation or of the views given or implied. PolyPeptide, together with its directors, officers, employees and
advisors, shall have no liability whatsoever for any errors or omissions or any loss howsoever arising, directly or indirectly, from any use of this Presentation, its information or its contents or otherwise arising
in connection therewith. PolyPeptide reserves the right to amend or replace the Presentation at any time, and undertakes no obligation to provide the recipients with access to any additional information.
Neither PolyPeptide, its directors, officers, employees or advisors nor any other person shall not be obligated to update or correct the information set forth in the Presentation (except as required by
applicable laws and regulations). Nothing in this Presentation is, or should be relied upon as, a promise or representation as to the future.
To the extent available, the industry, market and competitive position data contained in this Presentation has come from official or third-party sources as of at 31 December 2020. Third party industry
publications, studies and surveys generally state that the data contained therein have been obtained from sources believed to be reliable, but that there is no guarantee of the accuracy or completeness of
such data. While the Group believes that each of these publications, studies and surveys has been prepared by a reputable source, the Group has not independently verified the data contained therein and
there is no guarantee that such data has been verified by those sources. In addition, certain of the industry, market and competitive position data contained in this Presentation come from the Group's own
internal research and estimates based on the knowledge and experience of the Group's management in the market in which the Group operates. While the Group believes that such research and estimates
are reasonable and reliable, they, and their underlying methodology and assumptions, have not been verified by any independent source for accuracy or completeness and are subject to change without
notice. Accordingly, undue reliance should not be placed on any of the industry, market or competitive position data contained in this Presentation.
Unaudited Financial Results
The financial information contained in this Presentation is unaudited.
Forward-looking information
This Presentation has been prepared by PolyPeptide and includes forward-looking information and statements concerning the outlook for its business. These statements are based on current expectations,
estimates and projections about the factors that may affect its future performance. These expectations, estimates and projections are generally identifiable by statements containing words such as 'expects',
'believes', 'estimates', 'targets', 'plans', 'outlook' or similar expressions. There are numerous risks, uncertainties and other factors, many of which are beyond PolyPeptide's control, that could cause its actual
results to differ materially from the forward-looking information and statements made in this Presentation and which could affect its ability to achieve its stated targets. Although PolyPeptide believes that its
expectations reflected in any such forward-looking statement are based upon reasonable assumptions, it can give no assurance that those expectations will be achieved.
Alternative Financial Performance Measures (APM)
This Presentation contains references to operational indicators, such as customer projects, and alternative financial performance measures ("APM") that are not defined or specified by IFRS, including
EBITDA, adjusted EBITDA, adjusted EBITDA margin, net operating assets, return on net operating assets, capital expenditures, equity ratio, net working capital, free cash flow, net cash and total financial
debt. These APM should be regarded as complementary information to and not as substitutes of the Group's consolidated financial results based on IFRS. For the definitions of the main operational
indicators and APM used, including related abbreviations, as well as for selected reconciliations to IFRS, refer to the section "Definitions and reconciliations" in PolyPeptide Group AG's half-year report 2021
available at https://report.polypeptide.com/hyr/21.
THIS PRESENTATION IS NOT AN INVITATION TO PURCHASE SECURITIES OF POLYPEPTIDE OR THE GROUP.
GLOBAL SUPPORT FOR A QUALITY SOLUTION
2
PolyPeptide
GROUPView entire presentation